Use of the combined first-trimester screen in high- and low-risk patient populations after introduction of noninvasive prenatal testing

Journal of Ultrasound in Medicine

Volumn 34, Issue 8, 2015, Pages 1423-1428

  Larion, Sebastian ^a   Warsof, Steven L ^a   Romary, Letty ^a   Mlynarczyk, Margaret ^a   Peleg, David ^b   Abuhamad, Alfred Z ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b Rebecca Sieff Government Hospital   (Israel)

Author keywords

Combined first trimester screen; Fetal aneuploidy; First trimester screen; Noninvasive prenatal testing; Obstetric ultrasound; Prenatal screening

Indexed keywords

DIAGNOSIS; NEONATAL MONITORING; ULTRASONICS;

FETAL ANEUPLOIDY; FIRST TRIMESTERS; HIGH-RISK PATIENTS; PATIENT POPULATION; PRENATAL TESTING; STATISTICAL SIGNIFICANCE; TIME OF DELIVERY; ULTRASOUND EXAMINATION;

RISK PERCEPTION;

BLOOD; DOWN SYNDROME; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MALE; MASS SCREENING; MATERNAL SERUM SCREENING TEST; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PRENATAL DIAGNOSIS; PREVALENCE; PROCEDURES; REPRODUCIBILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICS AND NUMERICAL DATA; UNITED STATES;

DOWN SYNDROME; FEMALE; HUMANS; MALE; MASS SCREENING; MATERNAL SERUM SCREENING TESTS; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 84938086637     PISSN: 02784297     EISSN: 15509613     Source Type: Journal    
DOI: 10.7863/ultra.34.8.1423     Document Type: Article

References (21)

1. Wapner R, Thom E, Simpson JL, et al. First-trimester screening for trisomies 21 and 18. N Engl J Med 2003; 349:1405-1413.
2. American College of Obstetricians and Gynecologists Committee on Practice Bulletins. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 2007; 109:217-227.
3. Palomaki GE, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011; 13:913-920.
4. Larion MS, Warsof SL, Romary L, Mlynarczyk M, Peleg D, Abuhamad AZ. Uptake of noninvasive prenatal testing at a large academic referral center. Am J Obstet Gynecol 2014; 211:651.e1-651.e7.
5. Haymon L, Simi E, Moyer K, Aufox S, Ouyang DW. Clinical implementation of noninvasive prenatal testing among maternal fetal medicine specialists. Prenat Diagn 2014; 34:416-423.
6. Nicolaides KH, Syngelaki A, Ashoor G, Birdir C, Touzet G. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. Am J Obstet Gynecol 2012; 207:374.e1-374.e6.
7. American College of Obstetricians and Gynecologists Committee on Genetics. Committee Opinion No. 545: noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol 2012; 120:1532-1534.
8. Bianchi DW, Parker RL, Wentworth J, et al. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med 2014; 370:799-808.
9. Position Statement from the Italian College of Fetal Maternal Medicine: non-invasive prenatal testing (NIPT) by maternal plasma DNA sequencing. J Prenat Med 2013; 7:19-20.
10. Brar H, Wang E, Struble C, Musci TJ, Norton ME. The fetal fraction of cell-free DNA in maternal plasma is not affected by a priori risk of fetal trisomy. J Matern Fetal Neonatal Med 2013; 26:143-145.
11. Hudecova I, Sahota D, Heung MM, et al. Maternal plasma fetal DNA fractions in pregnancies with low and high risks for fetal chromosomal aneuploidies. PLoS One 2014; 9:e88484.
12. Gil MM, Quezada MS, Bregant B, Ferraro M, Nicolaides KH. Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies. Ultrasound Obstet Gynecol 2013; 42:34-40.
13. Song Y, Liu C, Qi H, Zhang Y, Bian X, Liu J. Noninvasive prenatal testing of fetal aneuploidies by massively parallel sequencing in a prospective Chinese population. Prenat Diagn 2013; 33:700-706.
14. Friel LA, Czerwinski JL, Singletary CN. The impact of noninvasive prenatal testing on the practice of maternal-fetal medicine. Am J Perinatol 2014; 31:759-764.
15. de Graaf IM, Tijmstra T, Bleker OP, van Lith JM. Women's preference in Down syndrome screening. Prenat Diagn 2002; 22:624-629.
16. Druzin ML, Chervenak F, McCullough LB, Blatman RN, Neidich JA. Should all pregnant patients be offered prenatal diagnosis regardless of age? Obstet Gynecol 1993; 81:615-618.
17. Dormandy E, Michie S, Hooper R, Marteau TM. Low uptake of prenatal screening for Down syndrome in minority ethnic groups and socially deprived groups: a reflection of women's attitudes or a failure to facilitate informed choices? Int J Epidemiol 2005; 34:346-352.
18. Taylor JB, Chock VY, Hudgins L. NIPT in a clinical setting: an analysis of uptake in the first months of clinical availability. J Genet Couns 2014; 23:72-78.
19. Sayres LC, Allyse M, Norton ME, Cho MK. Cell-free fetal DNA testing: a pilot study of obstetric healthcare provider attitudes toward clinical implementation. Prenat Diagn 2011; 31:1070-1076.
20. Chetty S, Garabedian MJ, Norton ME. Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening. Prenat Diagn 2013; 33:542-546.
21. Larion S, Warsof SL, Romary L, Mlynarczyk M, Peleg D, Abuhamad AZ. Association of combined first-trimester screen and noninvasive prenatal testing on diagnostic procedures. Obstet Gynecol 2014; 123:1303-1310.